SCHEMBL29870909

SCHEMBL29870909

Cc1scc(C#N)c1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31612008 0.80 TSHR (0.36)
SCHEMBL15691410 0.78 TSHR (0.34)
SCHEMBL16572130 0.78 TSHR (0.34)
SCHEMBL27502465 0.76
SCHEMBL29096981 0.76
Hydrochloric Acid SCHEMBL27567865 0.75 GRM6 (0.37)
SCHEMBL5988699 0.72 TSHR (0.30)
SCHEMBL5987300 0.72 MAPK8 (0.30)
SCHEMBL17614995 0.72 TSHR (0.30)
SCHEMBL15417508 0.70 GPR35 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4725493-A2 POLYCYCLIC COMPOUNDS FOR INHIBITING RNA HELICASE DHX33 AND USE THEREOF Shenzhen Keye Life Technologies, Co., Ltd. (CN) 2026-04-15 EP disclosed
US-20250295652-A1 Inhibitors of Molluscum Contagiosum Infection and Methods Using the Same UNIV PENNSYLVANIA (US) 2025-09-25 US disclosed
CN-112538078-B Polycyclic compound for inhibiting DHX33 helicase 成都开悦生命科技有限公司 2024-03-19 CN disclosed
CN-112661754-B Polycyclic compound for inhibiting RNA helicase DHX33 成都开悦生命科技有限公司 2023-06-16 CN disclosed
US-20230146233-A1 A CLASS OF POLYCYCLIC COMPOUNDS INHIBITING RNA HELICASE DHX33 AND THE APPLICATION THEREOF SHENZHEN KEYE LIFE TECHNOLOGIES, CO., LTD (CN) 2023-05-11 US disclosed
EP-4089089-A1 POLYCYCLIC COMPOUNDS FOR INHIBITING RNA HELICASE DHX33 AND USE THEREOF Shenzhen Keye Life Technologies, Co., Ltd. (CN) 2022-11-16 EP disclosed
WO-2022127199-A1 POLYCYCLIC COMPOUNDS FOR INHIBITING RNA HELICASE DHX33 AND USE THEREOF 深圳开悦生命科技有限公司 2022-06-23 WO disclosed